The lives of more than six million people in the United States are negatively impacted by the diagnosis of Advanced Heart Failure. Financial burden, repeated hospitalizations, and declining quality of life account for poor outcomes. Implantation of a left ventricular assist device (LVAD) has offered the promise of improved financial, clinical, and functional outcomes for those awaiting or ineligible for heart transplantation. Right Heart Failure (RHF), however, threatens positive outcomes as it remains the leading cause of mortality and morbidity following LVAD placement. Despite extensive research, there is no comprehensive tool for RHF risk assessment and stratification for this population. The D.N.P. project aimed to adapt and implement a scoring tool for such assessment. Providers rated the assessment tool to be feasible and useful in practice. Though limited by a small number of LVAD patients, RHF risk was found to fluctuate for each patient throughout the phases of care, and no single parameter consistently trended in the same direction as the combined score. This pilot project should inspire future projects aimed at identifying risk for RHF which can offer opportunities for preventative care and realization of all positive outcomes for LVAD recipients.
","abstract_html":"<p>The lives of more than six million people in the United States are negatively impacted by the diagnosis of Advanced Heart Failure. Financial burden, repeated hospitalizations, and declining quality of life account for poor outcomes. Implantation of a left ventricular assist device (LVAD) has offered the promise of improved financial, clinical, and functional outcomes for those awaiting or ineligible for heart transplantation. Right Heart Failure (RHF), however, threatens positive outcomes as it remains the leading cause of mortality and morbidity following LVAD placement. Despite extensive research, there is no comprehensive tool for RHF risk assessment and stratification for this population. The D.N.P. project aimed to adapt and implement a scoring tool for such assessment. Providers rated the assessment tool to be feasible and useful in practice. Though limited by a small number of LVAD patients, RHF risk was found to fluctuate for each patient throughout the phases of care, and no single parameter consistently trended in the same direction as the combined score. This pilot project should inspire future projects aimed at identifying risk for RHF which can offer opportunities for preventative care and realization of all positive outcomes for LVAD recipients. </p>","abstract_has_math":false,"creators":["Cyr, Mary-Ann Lombardi"],"institution":null,"degree_name":"Doctor of Nursing Practice (DNP)","degree_level":"Open Access Thesis","degree_discipline":"Yale University School of Nursing","degree_department":null,"school":null,"contributors":["Laura K. Andrews","Jessica S. Coviello"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022-01-01T08:00:00Z","date_published":"2022-01-01T08:00:00Z","updated_at":"2026-07-24T06:16:14Z","subjects":["Adult Critical Care, Cardiology, Cardiothoracic Surgery, Heart Failure, Left Ventricular Assist Device, Right Heart Failure"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://elischolar.library.yale.edu/ysndt/1131","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Laura K. Andrews","Jessica S. Coviello"]},{"key":"dc:creator","label":"Author","values":["Cyr, Mary-Ann Lombardi"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"thesis:degree_discipline","label":"Discipline","values":["Yale University School of Nursing"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Nursing Practice (DNP)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Adult Critical Care, Cardiology, Cardiothoracic Surgery, Heart Failure, Left Ventricular Assist Device, Right Heart Failure"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://elischolar.library.yale.edu/ysndt/1131"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The lives of more than six million people in the United States are negatively impacted by the diagnosis of Advanced Heart Failure. Financial burden, repeated hospitalizations, and declining quality of life account for poor outcomes. Implantation of a left ventricular assist device (LVAD) has offered the promise of improved financial, clinical, and functional outcomes for those awaiting or ineligible for heart transplantation. Right Heart Failure (RHF), however, threatens positive outcomes as it remains the leading cause of mortality and morbidity following LVAD placement. Despite extensive research, there is no comprehensive tool for RHF risk assessment and stratification for this population. The D.N.P. project aimed to adapt and implement a scoring tool for such assessment. Providers rated the assessment tool to be feasible and useful in practice. Though limited by a small number of LVAD patients, RHF risk was found to fluctuate for each patient throughout the phases of care, and no single parameter consistently trended in the same direction as the combined score. This pilot project should inspire future projects aimed at identifying risk for RHF which can offer opportunities for preventative care and realization of all positive outcomes for LVAD recipients.
"]},{"key":"dc:title","label":"Title","values":["Assessing Risk For Right Heart Failure After Left Ventricular Assist Device Implantation"]}]}],"canonical_facts":{"dc:contributor":["Laura K. Andrews","Jessica S. Coviello"],"dc:creator":["Cyr, Mary-Ann Lombardi"],"dc:description.abstract":["The lives of more than six million people in the United States are negatively impacted by the diagnosis of Advanced Heart Failure. Financial burden, repeated hospitalizations, and declining quality of life account for poor outcomes. Implantation of a left ventricular assist device (LVAD) has offered the promise of improved financial, clinical, and functional outcomes for those awaiting or ineligible for heart transplantation. Right Heart Failure (RHF), however, threatens positive outcomes as it remains the leading cause of mortality and morbidity following LVAD placement. Despite extensive research, there is no comprehensive tool for RHF risk assessment and stratification for this population. The D.N.P. project aimed to adapt and implement a scoring tool for such assessment. Providers rated the assessment tool to be feasible and useful in practice. Though limited by a small number of LVAD patients, RHF risk was found to fluctuate for each patient throughout the phases of care, and no single parameter consistently trended in the same direction as the combined score. This pilot project should inspire future projects aimed at identifying risk for RHF which can offer opportunities for preventative care and realization of all positive outcomes for LVAD recipients.
"],"dc:identifier":["https://elischolar.library.yale.edu/ysndt/1131"],"dc:subject":["Adult Critical Care, Cardiology, Cardiothoracic Surgery, Heart Failure, Left Ventricular Assist Device, Right Heart Failure"],"dc:title":["Assessing Risk For Right Heart Failure After Left Ventricular Assist Device Implantation"],"thesis:degree_discipline":["Yale University School of Nursing"],"thesis:degree_level":["Open Access Thesis"],"thesis:degree_name":["Doctor of Nursing Practice (DNP)"]},"updated_at":"2026-07-24T06:16:14Z"}